Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): comment on the appraisal consultation from NCRI/Royal College of Physicians/RCR/ACP/JCCO

Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): comment on the appraisal consultation from NCRI/Royal College of Physicians/RCR/ACP/JCCO

Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): comment on the appraisal consultation from NCRI/Royal College of Physicians/RCR/ACP/JCCO
10 March 2011
(15.4 Kb 4 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 08 March 2011